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Abstract: Subthalamic nucleus (StN) deep brain stimulation (DbS) is well established for the treat-
ment of the motor symptoms of Parkinson’s disease (Pd). however, the effect of stn dBs on autonomic 
symptoms has not been well studied. We examined 19 patients undergoing StN DbS for PD. the 
patients were administered a questionnaire to evaluate the pre-operative and post-operative autonomic 
function. all patients reported a significant post dBs improvement of one or more symptoms of the 
autonomic dysfunction (urinary and gastrointestinal function). In particular, we have shown the most 
significant improvement in the urinary function after stn dBs. Further larger studies are required 
with respect to the effect of StN DbS on the autonomic function.
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INtRODuCtION
Parkinson’s disease is a common neurodegenerative disorder, clinically characte-
rized by the progression of several motor and non-motor neurological functions [1]. 
Non-motor symptoms including autonomic dysfunction increase with neurological 
impairment, disease duration and progression of the underlying neurodegenera-
tive process. In recent years it has been increasingly recognized that in some 
patients the non-motor symptoms of Pd can be even more disabling than motor 
symptoms [2, 3]. In advanced stages of the disease, many patients will experien-
ce reduced efficacy of medication with fluctuations in symptoms and dyskinesias. 
Surgical treatment with deep brain stimulation of the subthalamic nucleus 
(stn-dBs) is well established for treating the motor symptoms for advanced Pd 
and is the most effective surgical procedure for patients with intractable fluctu-
ations [4, 5]. however, the effect of stn-dBs on autonomic symptoms has not 
been well studied. Dysautonomia such as constipation, urinary dysfunction inc-
luding urgency, increased frequency or incontinence is frequently encountered, 
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particularly at the advanced stages of the disease when dBs is considered as 
a therapeutic option. It is therefore of clinical relevance to investigate whether 
dBs has also an effect on the urinary or gastrointestinal function. Previous small 
studies have indicated that some autonomic symptoms may improve following 
stn dBs [6–10].
In this study, we investigated whether gastrointestinal and urinary symptoms 
of Pd improve following stn dBs. 
MAtERIALS AND MEthODS
the study enrolled 19 patients (4 females, 15 males) aged 59.37 ± 10.00 years 
(range 32 to 70 years), and mean duration of a disease of 11.9 ± 4.5 years who 
were selected to undergo stn-dBs at Jagiellonian University department of neu-
rosurgery.
the patients were approved for surgery according to the following selection 
criteria: diagnosis of Pd according to Uk Parkinson’s disease society Brain Bank 
Clinical diagnostic criteria [11], disease duration >5 years, age under 70 years, 
disabling motor fluctuations despite optimal adjustment of antiparkinsonian me-
dication, normal magnetic resonance imaging (MRI) studies of the brain, no signi-
ficant cognitive impairment (score on the Mini-Mental state of examination, >24), 
no psychiatric or behavioural disturbances, and no surgical contraindications.
the study was approved by the ethics Committee of Jagiellonian University 
Collegium Medicum and the patients submitted their written informed consent. 
ASSESSMENtS
evaluation of signs of Pd was performed using the motor components of the 
Unified Parkinson’s disease rating scale (UPdrs). Patients were evaluated pre-
operatively and post operatively for three months. assessment of the motor scale 
was carried out at baseline (before subthalamic nucleus dBs), both in the “on” 
condition with medication, and without medication after withdrawal overnight in 
the “off” condition, and for 3 months following the surgery. after the surgery, the 
motor score was performed in “off” medication and stimulation “on” condition. 
all patients were evaluated by the same movement disorder specialist at baseline 
and during the 3 month follow-up visit.
We used autonomic function questionnaire explored components of the gastro-
intestinal and urinary tract. Gastrointestinal symptoms were studied by assessing 
the patient’s bowel function including frequency, bowel dynamics, difficulty with 
defecation, dysphagia, abdominal discomfort or pain, postprandial bloating and 
weight loss. Urinary symptoms of Pd were studied by assessing the patients’ 
frequency, urgency, nocturia, and satisfaction with their urinary function.
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Assessment of gAstrointestinAl symptoms
All patients completed a self-administered questionnaire that included nine symp-
toms (heartburn, abdominal pain, sialorrhea, constipation, intensity of difficulty 
with defecation, rectal burning during or after defecation, dysphagia, bloating, 
weight loss) to assess subjective gastrointestinal symptoms. the severity of each 
of these symptoms was scored (0–5 points) as: absent (0), or severe (5). Factor 
analyses were also performed.
Assessment of urinAry symptoms
the patients completed a self-reported questionnaire regarding the presence or 
absence of five urinary symptoms (nocturia, urgency, incontinence, frequency, 
hesitancy). The severity of each of these symptoms was scored (0–5 points) as: 
absent (0), or severe (5). Factor analyses were also performed. 
surgicAl procedure
Pre-operative 1.5T MRI (T2, T1 with contrast enhancement) was performed. The 
targeting of the subthalamic nucleus (stn) was performed on surgical planning 
workstation (stealth, medtronic inc., minneapolis, mn) and software (framelink, 
medtronic inc.). the target site (stn) was identified on mri, with reference to 
a standard stereotactic atlas and coordinates. in the day of the surgery the rm 
stereotactic frame was placed on the head of the patient under local anesthesia, 
and ct with contrast enhancement was performed. fusion of ct and mri was 
then performed. patients received a short-term sedation during drilling of the 
burr hole and introducing 3–5 microelektrodes. Microelectrode recordings were 
carried out to identify the neuronal signals of stn. macrostimulation was then 
performed to confirm the appropriate location for rigidity, bradykinesia and tremor 
control and the assess for adverse effects of stimulation. When the best location 
had been established, permanent electrode (medtronic 3389, medtronic inc.) was 
inserted in the same position. under general anesthesia internal pulse generator 
(ipg) was placed into a subcutaneous pocket in the subclavicular region and 
connected to the electrode. the next day ct was performed and ipg was turned 
on. implantation of the second electrode and ipg, on the other side of the body, 
was performed usually two weeks later. standard initial settings of the ipg were 
as follows: 1–2 V, 130 Hz, 60 μs.
stAtisticAl AnAlysis
statistical analysis was performed using a Wilcoxon signed rank test to determine 
the relative difference between the preoperative and postoperative states in each 
patient. furthermore, to verify the normality of distribution of each variable, the 
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shapiro–wilk test was carried out. In case of normally distributed variables the 
t-test for dependent variables was applied. a spearman rank test was performed 
to determine whether there existed any correlations between the quantitative va-
riables. a p value of 0.05 was taken to be the statistical significance threshold. 
overall statistical analysis was prepared by means of statIstICa 10.0 package.
RESuLtS
All the procedures were performed without complications. DbS StN significantly 
improved patients’ motor performance (p <0.0005), decreasing UPdrs motor score 
in average 65%, from 55.2 ± 2.1 to 19.1 ± 1.1 (p <0.0002) in the “off” condition 
and significant decrease in average 71% from 37.6 ± 1.7 to 10.9 ± 0.8 (p <<0.0001) 
in “on” condition. table 1 presents the results of the UPdrs before and after 
dBs-stn. anti-parkinsonian drugs were reduced by 75% from baseline after 
the surgery (p <0.0002). the levodopa daily dose from a mean of 1144 (range 
600–2000) preoperatively to 283 (range 0–600). effects of dBs-stn on autonomic 
symptoms are listed in table 2. the most common autonomic symptoms reported 
t a b l e  1 
Effects of bilateral subthalamic nucleus stimulation on uPDRS score.
baseline 3 months follow-up Improvement % p-value
uPDRS
Part III
ON 37.6 ± 1.7 10.9 ± 0.8 71 p <<0.0001
OFF 55.2 ± 2.1 19.1 ± 1.1 65 0.0002
t a b l e  2
Effects of bilateral subthalamic nucleus stimulation on urinary and gastrointestinal dysfunction.
Class Parameter Preoperative Postoperative reduction % p-value
u
ri
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d
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n
ct
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n urgency 2.7 ± 0.4 0.3 ± 0.2  89  0.001 
Frequency 3.2 ± 0.4 1.0 ± 0.4  69  0.005
Nocturia 2.1 ± 0.5 0.6 ± 0.3  71 0.01
hesistancy 0.8 ± 0.3 0.3 ± 0.2  63 0.04
G
as
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n
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n
Weight loss 0.7 ± 0.2 0.0 ± 0.0 100  0.005
the intensity of problem 
with defecation
2.7 ± 0.4 1.4 ± 0.3  48  0.001
Constipation 3.8 ± 0.3 1.6 ± 0.3  58   0.0007
Dysphagia 1.6 ± 0.4 0.6 ± 0.3  63  0.008
Abdominal pain 1.6 ± 0.4 0.9 ± 0.3  43 0.02
Rectal burning during 
or after defecation
1.2 ± 0.3 0.7 ± 0.2  42 0.02
Sialorrhea 1.0 ± 0.4 0.3 ± 0.1  70 0.02
bloating 1.1 ± 0.3 0.8 ± 0.4  27 0.58
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prior to surgery were: constipation (95%), urine urgency (84%), frequency (84%) 
problems with defecation (84%) weight loss (58%) the least prevalent autonomic 
symptoms were: hesitancy, rectal burning during or after defecation and abdo-
minal pain. None of the patients had heartburn and urinary incontinence.
Following the stn-dBs weight loss was eliminated in all previous patients. 
the percentage of patients with dysphagia, constipation and difficulties with de-
fecation was significantly reduced. As compared with baseline, after DbS-StN the 
scores for frequency improved by 69%, those for urgency by 89%, and those for 
nocturia by 71%. effects of stn dBs on the most frequent autonomic dysfunction 
are presented in Figure 1.
Fig. 1. Effects of bilateral subthalamic stimulation on the most frequent autonomic dysfunction. 
Ordinate express the percentage of patients who reported these autonomic before and after  
surgery. Before: preoperative non motor symptom; after: postoperative non motor symptom.
DISCuSSION
Our results show that urinary and gastrointestinal symptoms of autonomic dys-
function associated with Pd are widespread and improve significantly in most 
patients who underwent StN-DbS surgery. After 3 months of StN stimulation all 
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the patients were improved, but to variable extension. the improvement in the 
motor scale was in line with most of the data published so far [3, 5]. the auto-
nomic dysfunction decreased considerably under chronic stimulation, in terms 
of the overall number of symptoms reported. the results of the questionnaire 
administrated before the electrode implantation were similar to those obtained 
in the previous study [7–9].
the improvement of dysautonomic fluctuations after chronic stimulation was 
remarkable especially for some symptoms. urinary dysfunction showed the gre-
atest reduction in the number of symptoms reported by patients after the sur-
gery. Frequency and urgency, which are one of the most debilitating autonomic 
symptoms were reported by more than 80% of the patients. after dBs, these 
symptoms decreased significantly, 31% of patients reported having had a few 
episodes of urgency and frequency. Gastrointestinal functions were less respon-
sive to stn dBs.
observed differences between the responses of various autonomic symptoms 
might be partially explained by the existence of different mechanisms of the au-
tonomic regulation. It is well known that more regions of the brain are involved 
in Pd and underlie the development of non-motor symptoms, including urinary 
and bowel symptoms. studies of the basal ganglia in animal models of Pd have 
shown that nigrostriatal degeneration of dopaminergic neurons leads to urgency 
and frequency [12]. the severity of bladder dysfunction seems to be associated 
with the relative degeneration of the caudate nucleus, amongst other areas [13]. 
according to the neuropathological model of disease progression developed by 
braak et al. the threshold seems to be the involvement of the neocortex in the 
disease process and the occurrence of bladder symptoms [14]. Functional imaging 
studies have suggested some stn dBs modulation of brain areas involved in au-
tonomic control. Pet studies have supported that stn-dBs leads to changes in 
neural activation of frontal cortical regions including supplementary motor area 
[15, 16] as well as anterior cingulate gyrus [16, 17]. these structures play a role 
in urinary function as has been revealed in Pet [18–20] and MrI studies [21]. Ga-
strointestinal function is associated with autonomic centres such as the frontal 
cortex, cingulate cortex, insula, thalami, basal ganglia and periaqueductal grey 
matter [22–24]. the activation of nerve fibres projecting from or to hypothalamus 
and crossing the subthalamic nucleus might have a possible effect on gastroin-
testinal function induced by DbS-StN. the discrepancies between urinary and 
gastrointestinal improvement might result from the fact that the bowel function 
depends not only on central but also peripheral autonomic structures which 
might not be the system modulated by StN DbS.
the results of this study show that autonomic symptoms respond to StN 
dBs. however, the results were not equal to all categories of symptoms. Urinary 
dysfunction showed a remarkable decrease after the chronic stimulation. Further 
studies are required with respect to the improvement of non-motor symptoms 
after StN-DbS.
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